Omnicell, Inc. (OMCL)
NASDAQ: OMCL · IEX Real-Time Price · USD
26.16
-0.49 (-1.84%)
At close: Jul 2, 2024, 4:00 PM
25.65
-0.51 (-1.95%)
After-hours: Jul 2, 2024, 4:04 PM EDT

Omnicell Revenue

Omnicell had revenue of $1.10B in the twelve months ending March 31, 2024, down -13.02% year-over-year. Revenue in the quarter ending March 31, 2024 was $246.15M, a -15.30% decrease year-over-year. In the year 2023, Omnicell had annual revenue of $1.15B, a decrease of -11.48%.

Revenue (ttm)
$1.10B
Revenue Growth
-13.02%
P/S Ratio
1.09
Revenue / Employee
$302,092
Employees
3,650
Market Cap
1.20B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.15B-148.84M-11.48%
Dec 31, 20221.30B163.93M14.48%
Dec 31, 20211.13B239.81M26.88%
Dec 31, 2020892.21M-4.82M-0.54%
Dec 31, 2019897.03M109.72M13.94%
Dec 31, 2018787.31M74.60M10.47%
Dec 31, 2017712.71M16.81M2.41%
Dec 31, 2016695.91M211.35M43.62%
Dec 31, 2015484.56M43.66M9.90%
Dec 31, 2014440.90M60.32M15.85%
Dec 31, 2013380.59M66.56M21.19%
Dec 31, 2012314.03M68.49M27.90%
Dec 31, 2011245.54M23.13M10.40%
Dec 31, 2010222.41M8.95M4.19%
Dec 31, 2009213.46M-38.41M-15.25%
Dec 31, 2008251.87M38.78M18.20%
Dec 31, 2007213.08M58.37M37.73%
Dec 31, 2006154.71M33.19M27.31%
Dec 31, 2005121.52M-2.42M-1.95%
Dec 31, 2004123.94M21.81M21.36%
Dec 31, 2003102.13M14.44M16.46%
Dec 31, 200287.69M789.00K0.91%
Dec 31, 200186.90M19.54M29.00%
Dec 31, 200067.37M12.09M21.88%
Dec 31, 199955.27M7.06M14.64%
Dec 31, 199848.21M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Phreesia 373.67M
Xencor 162.18M
Establishment Labs Holdings 155.79M
Immatics 80.95M
Vir Biotechnology 79.60M
Spyre Therapeutics 688.00K
Revenue Rankings